HeartWare International Inc  

(Public, NASDAQ:HTWR)   Watch this stock  
Find more results for htwr
33.19
-0.91 (-2.67%)
Feb 12 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 32.74 - 34.66
52 week 25.01 - 95.59
Open 34.66
Vol / Avg. 256,689.00/754,350.00
Mkt cap 571.17M
P/E     -
Div/yield     -
EPS -4.22
Shares 17.32M
Beta 0.38
Inst. own 131%
Mar 15, 2016
HeartWare International Inc at Barclays Global Healthcare Conference - 10:45AM EDT - Add to calendar
Feb 25, 2016
Q4 2015 HeartWare International Inc Earnings Release - 9:30AM EST - Add to calendar
Feb 25, 2016
Q4 2015 HeartWare International Inc Earnings Call - 8:00AM EST - Add to calendar
Feb 10, 2016
HeartWare International Inc at Leerink Partners Global Healthcare Conference - Webcast
Jan 11, 2016
HeartWare International Inc at JPMorgan Healthcare Conference (Q&A) - Webcast
Jan 11, 2016
HeartWare International Inc at JPMorgan Healthcare Conference
Dec 8, 2015
HeartWare International Inc at Oppenheimer Healthcare Conference - Webcast
Dec 1, 2015
HeartWare International Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 19, 2015
HeartWare International Inc at Canaccord Genuity Medical Technology & Diagnostics Forum - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -45.92% -6.96%
Operating margin -39.50% -0.04%
EBITD margin - -5.37%
Return on average assets -24.52% -4.54%
Return on average equity -61.22% -9.51%
Employees 585 -
CDP Score - -

Address

500 Old Connecticut Path
FRAMINGHAM, MA 1701
United States - Map
+1-508-7390873 (Phone)
+1-508-7390948 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump, the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery, directly adjacent to the heart. The Company's hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller, which circulates a cushion of blood.

Officers and directors

C. Raymond Larkin Jr. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Douglas Evan Godshall M.B.A. President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Seth L. Harrison M.D. Deputy Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Peter F. McAree Chief Financial Officer, Senior Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Jeffrey Adrian LaRose Executive Vice President, Chief Scientific Officer
Age: 52
Bio & Compensation  - Reuters
Lawrence Knopf Senior Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
James Schuermann Senior Vice President - Sales and Marketing
Age: 46
Bio & Compensation  - Reuters
Mark Strong Senior Vice President, Research and Development and Quality Assurance
Age: 43
Bio & Compensation  - Reuters
Robert Yocher Senior Vice President, Regulatory Affairs
Age: 63
Bio & Compensation  - Reuters
Katrin Leadley M.D. Chief Medical Officer
Age: 52
Bio & Compensation  - Reuters